skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

The article offers an introduction to the ongoing trends within the orphan drug market, focusing on the leading pharmaceutical players in this field. A growing number of companies have turned to deal-making activity with specialist firms in an effort to secure promising pipeline candidates. Datamonitor has identified 8 potential takeover targets for Big Pharma, which could enable rapid sales growth in the orphan drug market.

 

 

Highlights from the whitepaper include:

Net orphan drug sales difference, by company ($m), 2011–17

Sanofi's acquisition of Genzyme, a global leader in lysosomal storage disorder (LSD) enzyme replacement therapies

 



Orphan-Drugs-White-Paper

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: